Literature DB >> 17167857

High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.

Marko Hocevar1, Magdalena Avbelj, Barbara Perić, Janez Zgajnar, Nikola Besić, Tadej Battelino.   

Abstract

AIM: To prospectively determine the prevalence of germline CDKN2A mutations in the Slovenian cutaneous malignant melanoma (CMM) families.
METHODS: From January 2001 till the end of 2003 we prospectively screened 19 individuals from 11 CMM families, as well as 3 children with CMM aged from 6 to 13 years, with a negative family history.
RESULTS: Five distinct mutations were detected in 5 out of 11 screened families (10/19 individuals) and a previously recognized polymorphism was detected in a single family. Detected mutations were functionally deleterious (T281A, G68A, G301T, G71C and IVS - 1g>a). No mutations could be detected in 3 children.
CONCLUSIONS: The prevalence of CDKN2A mutations among Slovenian CMM families was high, indicating the need for genetic counseling.

Entities:  

Mesh:

Year:  2006        PMID: 17167857      PMCID: PMC2080476     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  14 in total

1.  High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.

Authors:  Michela Mantelli; Monica Barile; Paola Ciotti; Paola Ghiorzo; Francesca Lantieri; Lorenza Pastorino; Caterina Catricalà; Gabriella Della Torre; Ugo Folco; Paola Grammatico; Laura Padovani; Barbara Pasini; Dario Rovini; Paola Queirolo; Maria Luisa Rainero; Pier Luigi Santi; Roberto M Sertoli; Alisa M Goldstein; Giovanna Bianchi-Scarrà
Journal:  Am J Med Genet       Date:  2002-01-22

2.  Germline CDKN2A mutations in childhood melanoma.

Authors:  D C Whiteman; A Milligan; J Welch; A C Green; N K Hayward
Journal:  J Natl Cancer Inst       Date:  1997-10-01       Impact factor: 13.506

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

Authors: 
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

5.  Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.

Authors:  S Auroy; M F Avril; A Chompret; D Pham; A M Goldstein; G Bianchi-Scarrà; T Frebourg; P Joly; A Spatz; C Rubino; F Demenais; B Bressac-de Paillerets
Journal:  Genes Chromosomes Cancer       Date:  2001-11       Impact factor: 5.006

6.  Screening for tumour suppressor p16(CDKN2A) germline mutations in Israeli melanoma families.

Authors:  E A Yakobson; A Zlotogorski; R Shafir; M Cohen; M Icekson; M Landau; S Brenner; S Usher; H Peretz
Journal:  Clin Chem Lab Med       Date:  1998-08       Impact factor: 3.694

7.  Geographical variation in the penetrance of CDKN2A mutations for melanoma.

Authors:  D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac-de Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

8.  CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.

Authors:  M C Fargnoli; S Chimenti; G Keller; H P Soyer; V Dal Pozzo; H Höfler; K Peris
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

9.  Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.

Authors:  I J Byeon; J Li; K Ericson; T L Selby; A Tevelev; H J Kim; P O'Maille; M D Tsai
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

10.  A novel L94Q mutation in the CDKN2A gene in a melanoma kindred.

Authors:  Magdalena Avbelj; Marko Hocevar; Katarina Trebusak-Podkrajsek; Ciril Krzisnik; Tadej Battelino
Journal:  Melanoma Res       Date:  2003-12       Impact factor: 3.599

View more
  3 in total

1.  MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Authors:  Cristina Pellegrini; Francesca Botta; Daniela Massi; Claudia Martorelli; Fabio Facchetti; Sara Gandini; Patrick Maisonneuve; Marie-Françoise Avril; Florence Demenais; Brigitte Bressac-de Paillerets; Veronica Hoiom; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Loraine Marrett; Roberto Zanetti; Terence Dwyer; Nancy E Thomas; Colin B Begg; Marianne Berwick; Susana Puig; Miriam Potrony; Eduardo Nagore; Paola Ghiorzo; Chiara Menin; Ausilia Maria Manganoni; Monica Rodolfo; Sonia Brugnara; Emanuela Passoni; Lidija Kandolf Sekulovic; Federica Baldini; Gabriella Guida; Alexandros Stratigos; Fezal Ozdemir; Fabrizio Ayala; Ricardo Fernandez-de-Misa; Pietro Quaglino; Gloria Ribas; Antonella Romanini; Emilia Migliano; Ignazio Stanganelli; Peter A Kanetsky; Maria Antonietta Pizzichetta; Jose Carlos García-Borrón; Hongmei Nan; Maria Teresa Landi; Julian Little; Julia Newton-Bishop; Francesco Sera; Maria Concetta Fargnoli; Sara Raimondi
Journal:  Lancet Child Adolesc Health       Date:  2019-03-12

Review 2.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

Review 3.  CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition.

Authors:  Sock Hoai Chan; Jianbang Chiang; Joanne Ngeow
Journal:  Hered Cancer Clin Pract       Date:  2021-03-25       Impact factor: 2.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.